v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS

The following tables present the effect of the restatement on the Company’s previously issued condensed consolidated financial statements:

 

   As Previously
Reported (A)
   As
Restated (B)
  

Difference
(B) - (A)

 
CONSOLIDATED BALANCE SHEETS               
As of March 31, 2025               

Assets:

               
Cash and cash equivalents  $26,996,932   $2,425,391    (24,571,541)

Restricted cash (client funds, segregated)

   -    17,453,282    17,453,282 
Subscription receivable (asset)   8,200,000   -   (8,200,000)
Right of use (lease)   668,215    938,131    269,916 
Liabilities:               
Customer funds / Client funds payable   24,527,483    17,453,282    (7,074,201)
Operating lease liability, current   363,370    186,157    (177,213)
Operating lease liability, non-current   304,845    482,056    177,211 
Stockholders’ Equity:               
Common stock, par value   42,258    42,308    50 
Additional paid-in capital   17,938,279    14,262,445    (3,675,834)
Subscription receivable (contra-equity)   -    (8,000,000)   (8,000,000)
Additional paid-in capital, Series B Preferred stock   -    3,344,063    3,344,063 
Accumulated other comprehensive income (loss)   140,137    120,626    (19,511)
Accumulated deficit   (2,480,382)   (2,103,290)   377,092 
Noncontrolling interest   14,199    14,199    - 
                
CONSOLIDATED STATEMENTS OF OPERATIONS               
Three months ended March 31, 2025               
Technology & software   813,747    813,747    - 
Wealth management   1,534,852    1,534,852    - 
Investment and Brokerage   3,628,349    3,628,349    - 
Total revenue   5,976,948    5,976,948    - 
Technology & software   184,284    -    

(184,284

Wealth management   1,349,827    1,349,827    - 
Investment and Brokerage   1,583,278    1,767,562    184,284 
Total cost of sales   3,117,389    3,117,389    - 
Gross Profit   2,859,559    2,859,559    - 
General and administrative   2,140,270    2,136,678    (3,592)
Sales and marketing   276,204    276,204    - 
Depreciation   38,832    38,832    - 
Total operating expenses   2,455,306    2,451,714    (3,592)
Operating income (loss)   404,253    407,845    3,592 
Other income (expense):               
Other interest expense   4,483    4,483    - 
Other income (expense)   (304,188)   (98,206)   205,982 
Total other income (expense)   (299,705)   (93,723)   205,982 
Income (loss) before provision for income taxes   104,548    314,122    209,574
                
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)               
Three months ended March 31, 2025               
Change in APIC due to common control   882,771    676,789    (205,982)
                
CONSOLIDATED STATEMENTS OF CASH FLOWS               
Three months ended March 31, 2025               
Adjustments to reconcile net loss to net cash used in operating activities:               
Depreciation  $38,832    38,832    - 
Fixed assets, net  $25,425    25,425    - 
Net cash provided by (used in) operating activities     179,534       385,516       205,982  
Investing Activities:                        
Capitalized software     (54,234 )     (54,234 )     -  
Changes in paid-in capital     882,771       676,789       (205,982
Net cash used in investing activities   $ 828,537        622,555       (205,982
Financing Activities:                        
Borrowing from (payments to) line of credit     110,463       110,463       -  
Net proceeds from cares act - paycheck protection program.     (3,272 )     (3,272 )     -  
Net proceeds from SBA loan     (2,127 )     (2,127 )     -  
Related party advances     932,932       (6,780,895 )     (7,713,827 )
Series A Preferred cancelation     -       -       -  
Change in noncontrolling interest     (23,931 )     (21,310 )     2,621  
Net cash provided by (used in) financing activities     1,014,065       (6,699,762 )     (7,713,827 )
Effect of exchange rates     193,407       193,407       -  
 
                
   As Previously
Reported (A)
   As
Restated (B)
   Difference
(B) - (A)
 
CONSOLIDATED BALANCE SHEETS               
As of March 31, 2024               
Assets:               
Cash and cash equivalents  $38,945,123   $1,504,427    (37,440,696)
Restricted cash (client funds, segregated)   -    37,440,696    37,440,696 
Subscription receivable (asset)   8,200,000    -    (8,200,000)
Right of use (lease)   -    1,087,104    1,087,104 
Liabilities:               
Customer funds / Client funds payable   37,440,696    37,440,696    - 
Operating lease liability, current   -    291,330    291,330 
Operating lease liability, non-current   -    668,214    668,214 
Stockholders’ Equity:               
Common stock, par value   38,858    38,908    50 
Additional paid-in capital   13,475,375    13,530,075    54,700 
Subscription receivable (contra-equity)   -    (8,200,000)   (8,200,000)
Additional paid-in capital, Series B Preferred stock   3,329,964    3,329,964    - 
Accumulated other comprehensive income (loss)   (17,288)   (17,288)   - 
Accumulated deficit   (1,814,907)   (1,742,097)   72,810 
Noncontrolling interest   41,053    41,053    - 
                
CONSOLIDATED STATEMENTS OF OPERATIONS               
Three months ended March 31, 2024               
General and administrative  $2,299,134    2,226,324    (72,810)
Total operating expenses   2,386,347    2,313,537    (72,810)
Operating income (loss)   (44,246)   28,564    72,810 
Income (loss) before provision for income taxes   833,445    906,255    72,810 
Net income (loss)   833,445    906,255    72,810 
 
SCHEDULE OF CASH EQUIVALENTS AND RESTRICTED CASH

The following table reconciles the components of cash, cash equivalents, and restricted cash reported on the consolidated balance sheet to the total amounts shown in the consolidated statement of cash flows:

 

   March 31, 2025 (Unaudited; Restated)    December 31, 2024 (Audited; Restated)  
Cash and cash equivalents  $2,425,391   $13,850,168 
Restricted cash — client funds (segregated)   17,453,282    11,526,789 
Total cash, cash equivalents, and restricted cash  $19,878,673   $25,376,957 
SCHEDULE OF EXCHANGE RATE

The exchange rate at the reporting end date:

 

   March 31,
2025
  December 31,
2024
USD: AUD  $1.6018    1.6168 
USD: EUR  $0.9243    0.9662 
USD: GBP  $0.7740    0.7990 

 

Average exchange rate for the period:

 

   Q1 2025
USD: AUD  $1.5939 
USD: EUR  $0.9507 
USD: GBP  $0.7944